CZI has Committed 64 Million Dollars to the Research of Neurodegenerative Disorders

Neurodegenerative disorders affect millions of people across the world. They include Amyotrophic Lateral Sclerosis, Parkinson's disease, Huntington's disease, and Alzheimer's disease, among others. For most neurodegenerative diagnoses, there are no effective treatments, no…

Continue Reading CZI has Committed 64 Million Dollars to the Research of Neurodegenerative Disorders
The Vital Role of the National Amyotrophic Lateral Sclerosis (ALS) Registry
valelopardo / Pixabay

The Vital Role of the National Amyotrophic Lateral Sclerosis (ALS) Registry

According to a story from the Centers for Disease Control and Prevention, the National ALS Registry is playing a vital role in learning more about amyotrophic lateral sclerosis, a devastating…

Continue Reading The Vital Role of the National Amyotrophic Lateral Sclerosis (ALS) Registry

Potential New Treatment for Amyotrophic Lateral Sclerosis which Doesn’t Require Swallowing!

Amyotrophic lateral sclerosis (ALS) is a condition which affects the bodies nerve cells. It's neurodegenerative and progressive, causing the patient muscle weakness and muscle atrophy. It eventually results in paralysis.…

Continue Reading Potential New Treatment for Amyotrophic Lateral Sclerosis which Doesn’t Require Swallowing!
ICYMI: Creator of “SpongeBob SquarePants” Dies After Being Diagnosed With Amyotrophic Lateral Sclerosis
Tabeajaichhalt / Pixabay

ICYMI: Creator of “SpongeBob SquarePants” Dies After Being Diagnosed With Amyotrophic Lateral Sclerosis

According to a story from Buzzfeed News, Stephen Hillenburg, the creator of the smash hit children's cartoon SpongeBob SquarePants has passed away at age 57. Last year, Hillenburg had revealed…

Continue Reading ICYMI: Creator of “SpongeBob SquarePants” Dies After Being Diagnosed With Amyotrophic Lateral Sclerosis
Iowa Doctors Hesitant to Certify Medical Cannabis Patients
https://pixabay.com/en/marijuana-colorado-marijuana-grow-269851/

Iowa Doctors Hesitant to Certify Medical Cannabis Patients

According to the Des Moines Register, Iowa has a new medical marijuana program rolling out on December 1st, but many doctors in the state have reservations about enrolling patients. Iowa's…

Continue Reading Iowa Doctors Hesitant to Certify Medical Cannabis Patients
New Clinical Trial for Amyotrophic Lateral Sclerosis May be Coming Soon!
Source: Pixabay.com

New Clinical Trial for Amyotrophic Lateral Sclerosis May be Coming Soon!

In 1993, researchers found one of the causes of familial amyotrophic lateral sclerosis (ALS). ALS is a neurodegenerative disorder which affects the motor neurons. Motor neurons are responsible for transmitting…

Continue Reading New Clinical Trial for Amyotrophic Lateral Sclerosis May be Coming Soon!

ICYMI: Potential Treatment in the Works for Familial Amyotrophic Lateral Sclerosis

According to a story from telegram.com, a group of researchers from the University of Massachusetts medical school recently announced that they may have reached a major treatment breakthrough for genetically…

Continue Reading ICYMI: Potential Treatment in the Works for Familial Amyotrophic Lateral Sclerosis
Researchers were Wrong about the Cause of Muscular Dystrophy
qimono / Pixabay

Researchers were Wrong about the Cause of Muscular Dystrophy

For a long time, neuromuscular diseases such as muscular dystrophy, ALS, and inclusion body myopathy were thought to be caused as a result of toxic clumps of proteins such as TDP-43.…

Continue Reading Researchers were Wrong about the Cause of Muscular Dystrophy
This Company Just Endorsed New Patient Advocacy Guidelines
mohamed_hassan / Pixabay

This Company Just Endorsed New Patient Advocacy Guidelines

According to a story from globenewswire.com, the biopharmaceutical company Orphazyme has officially endorsed a set of guidelines that outline how rare disease patient advocacy organizations and drug companies should interact…

Continue Reading This Company Just Endorsed New Patient Advocacy Guidelines
Clinical Trial Data Looking Promising for an Experimental Amyotrophic Lateral Sclerosis Treatment
DarkoStojanovic / Pixabay

Clinical Trial Data Looking Promising for an Experimental Amyotrophic Lateral Sclerosis Treatment

According to a story from BioSpace, the biotechnology company BioElectron recently announced that the results from its Phase 2a clinical trial of its experimental product EPI-589 are looking positive. EPI-589…

Continue Reading Clinical Trial Data Looking Promising for an Experimental Amyotrophic Lateral Sclerosis Treatment
This Immunotherapy Could be a Useful Treatment for Amyotrophic Lateral Sclerosis
Bru-nO / Pixabay

This Immunotherapy Could be a Useful Treatment for Amyotrophic Lateral Sclerosis

According to a story from the Houston Chronicle, researchers are hoping that an immunotherapy treatment that was originally funded by an Ice Bucket Challenge grant could be a viable option…

Continue Reading This Immunotherapy Could be a Useful Treatment for Amyotrophic Lateral Sclerosis

New Information Revealed About The Link Between Neurodegenerative Diseases and Aging

According to a story from hms.harvard.edu, a recent study is revealing new information about the connection between aging and neurodegenerative disorders, such as Parkinson's disease, dementia, and amyotrophic lateral sclerosis.…

Continue Reading New Information Revealed About The Link Between Neurodegenerative Diseases and Aging

Tikomed Has Received Permission to Carry Out a Study of Their Experimental Drug for ALS in the UK

The speciality pharmaceutical company Tikomed has announced that the UK Medicines and Healthcare Products Regulatory Agency has granted the company permission to go ahead with a Phase 2 clinical study.…

Continue Reading Tikomed Has Received Permission to Carry Out a Study of Their Experimental Drug for ALS in the UK